| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Friedrich Luft | Q20753057 |
| Florian Herse | Q47804678 | ||
| Ralf Dechend | Q63812628 | ||
| Anne C Staff | Q87163921 | ||
| P2093 | author name string | Dominik N Müller | |
| Lydia Hering | |||
| P2860 | cites work | A molecular variant of angiotensinogen associated with preeclampsia | Q24309422 |
| Soluble endoglin contributes to the pathogenesis of preeclampsia | Q28244053 | ||
| Role of tissue factor in hemostasis, thrombosis, and vascular development | Q28259220 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| The immunology of preeclampsia | Q33548004 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy | Q34182166 | ||
| Latest advances in understanding preeclampsia | Q34425288 | ||
| Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia | Q35681821 | ||
| Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy | Q35699115 | ||
| Oxidative stress and preeclampsia: rationale for antioxidant clinical trials | Q35869763 | ||
| Preeclampsia: recent insights | Q36288757 | ||
| The role of RAS in the pathogenesis of preeclampsia | Q36467563 | ||
| Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia | Q37250421 | ||
| Angiotensinogen T235 expression is elevated in decidual spiral arteries | Q37372462 | ||
| Preeclampsia: an excessive maternal inflammatory response to pregnancy | Q40824430 | ||
| Etiology and pathogenesis of preeclampsia: current concepts | Q40835002 | ||
| Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy | Q40841949 | ||
| Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction | Q43744794 | ||
| Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation | Q43912171 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells | Q44320558 | ||
| AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
| Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation | Q45069619 | ||
| Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
| Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith | Q46801256 | ||
| Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness | Q46841539 | ||
| Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
| Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. | Q52933863 | ||
| Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. | Q52940276 | ||
| Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of Preeclampsia | Q56981931 | ||
| Dysregulation of the Circulating and Tissue-Based Renin-Angiotensin System in Preeclampsia | Q56981959 | ||
| Trophoblast and the Endometrium—A Workshop Report | Q60221776 | ||
| Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen | Q71695937 | ||
| Preeclampsia -- a state of sympathetic overactivity | Q71723202 | ||
| A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats | Q72059493 | ||
| Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension | Q73128397 | ||
| Reproductive tissue renin gene expression in preeclampsia | Q73300232 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension | Q74126541 | ||
| Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells | Q74188076 | ||
| Explaining and predicting preeclampsia | Q80223255 | ||
| Agonistic autoantibodies and rejection of renal allografts | Q81386151 | ||
| Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature | Q81423834 | ||
| Pre-eclampsia | Q81446389 | ||
| P433 | issue | 6 | |
| P921 | main subject | pre-eclampsia | Q61335 |
| autoantibody | Q785022 | ||
| maternal health | Q6786626 | ||
| P304 | page(s) | 697-703 | |
| P577 | publication date | 2008-04-09 | |
| P1433 | published in | Journal of Molecular Medicine | Q6295593 |
| P1476 | title | AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia | |
| P478 | volume | 86 |
| Q28069689 | A Dormant Microbial Component in the Development of Preeclampsia |
| Q38246351 | A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia |
| Q36683260 | Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats |
| Q47795663 | Angiotensin-converting enzyme and adducin-1 polymorphisms in women with preeclampsia and gestational hypertension |
| Q107324240 | Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19 |
| Q47447474 | Autoantibodies against AT1 and α1-adrenergic receptors predict arterial stiffness progression in normotensive subjects over a 5-year period |
| Q57159484 | B Regulatory Cells: Players in Pregnancy and Early Life |
| Q33789436 | B cells: the old new players in reproductive immunology |
| Q37200099 | Differential [Ca2+]i signaling of vasoconstriction in mesenteric microvessels of normal and reduced uterine perfusion pregnant rats |
| Q50559785 | Downregulation of apelin in the human placental chorionic villi from preeclamptic pregnancies. |
| Q30769610 | Hypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 study |
| Q35029700 | Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes |
| Q35690463 | Identification of the primary outcomes that result from deficient spiral arterial modification in pregnant mice. |
| Q37786350 | Immunologic characteristics of preeclampsia, a comprehensive review |
| Q34051510 | Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis |
| Q35850254 | Induction of heme oxygenase-1 shifts the balance from proinjury to prosurvival in the placentas of pregnant rats with reduced uterine perfusion pressure |
| Q36241932 | International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. |
| Q57127734 | Lower circulating angiotensin II levels are related to the severity of preeclampsia and its risk as disclosed by a specific bioassay |
| Q37748773 | Markers of preeclampsia and the relationship to cardiovascular disease: review of the twenty-first century literature |
| Q38017497 | Pathogenesis of pre-eclampsia: marinobufagenin and angiogenic imbalance as biomarkers of the syndrome |
| Q26865332 | Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology |
| Q64226376 | Placental CX3CL1 is Deregulated by Angiotensin II and Contributes to a Pro-Inflammatory Trophoblast-Monocyte Interaction |
| Q37278804 | Potential markers of preeclampsia--a review |
| Q34979773 | Protecting against vascular disease in brain |
| Q81752844 | Putting pressure on pre-eclampsia |
| Q36537709 | RAS in Pregnancy and Preeclampsia and Eclampsia |
| Q26828621 | Rat placentation: an experimental model for investigating the hemochorial maternal-fetal interface |
| Q34404445 | Recent insights into the pathophysiology of preeclampsia |
| Q35363716 | Regulation of soluble fms-like tyrosine kinase-1 production in response to placental ischemia/hypoxia: role of angiotensin II. |
| Q34254466 | Sera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assay |
| Q92690983 | Systemic Outcomes of (Pyr1)-Apelin-13 Infusion at Mid-Late Pregnancy in a Rat Model with Preeclamptic Features |
| Q34785051 | The renin-angiotensin-aldosterone system in adolescent offspring born prematurely to mothers with preeclampsia |
| Q82893732 | Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy |
Search more.